Add-on to Micamlo BP Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 309 participants.

Also called NCT01975246

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 309 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01975246
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01975246. Randomized; double masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2016-11-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Add-on to Micamlo BP Trial
Condition
Hypertension
Intervention (Drug)
Telmisartan + amlodipine
Intervention (Drug)
hydrochlorothiazide
Intervention (Drug)
Telmisartan + amlodipine
Intervention (Drug)
Placebo
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct01975246
Content hash
d2080600b378e4839d8f6b98cac1ce4e99dc698ad825885901d7ef0d1c3eb9a3